Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.
about
Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapyTreatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review.Management of pediatric and adult patients with medulloblastoma.Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors.Overcoming multiple drug resistance mechanisms in medulloblastoma.CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme InhibitorsBlockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.Pediatric neurosurgery-science, art, and humility: reflection of personal experience.Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)The biologic era of childhood medulloblastoma and clues to novel therapies.Secondary oligodendroglioma after postoperative irradiation for medulloblastoma: a case report and review of the literature.Local control in non-metastatic medulloblastoma.Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.The incidence of second brain tumors related to cranial irradiation.Effects of vertebral-body-sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastoma.The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studies.Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.BET bromodomain inhibition of MYC-amplified medulloblastoma.A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's OncolomTOR pathway as a potential target in a subset of human medulloblastoma.Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns.The evolution of medulloblastoma therapy to personalized medicine.EGF as a New Therapeutic Target for Medulloblastoma Metastasis.Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive.Long-term life expectancy for children with ependymoma and medulloblastoma.Functional and neuropsychological late outcomes in posterior fossa tumors in children.Secondary Solid Malignancies After High-Grade Glioma Treatment in Pediatric Patients.Evidence of high mortality in long term survivors of childhood medulloblastoma.Metachronous medulloblastoma and glioblastoma: Implications for clinical and technical aspects of re-irradiation.Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.Outcomes and patterns of care in a nationwide cohort of pediatric medulloblastoma: Factors affecting proton therapy utilization.Effect of O6-methylguanine-DNA methyltransferase methylation in medulloblastoma.
P2860
Q30389898-CB7AA008-3D6B-4136-AE8F-3E1AF6972691Q30764536-481BA535-D573-4020-AD83-9FB0EEE436C4Q30847947-51EE658D-9105-4395-A41E-C36FEB68E04BQ33894483-74B67003-081C-4853-8236-727C2CAB5717Q34500602-7CAF10EA-995E-4922-9D53-8863875301A6Q35640979-39D0A075-5594-4DCF-B4ED-9D0DE1F12277Q35952443-52CC2246-508C-4BE5-97BF-888C22EB39BEQ36106864-D0A261DD-7570-48F4-A258-8D31FF03F64CQ36310718-0E8FB155-3F18-4677-A51D-7A8A1FF7F267Q36772600-06EB4233-17BD-4B6E-9D20-96FF576F697CQ36901551-BED96A82-3484-4F78-9C93-CC9A11F62358Q37022200-CBE9924B-52E6-4CC5-A2CC-1525B4F49BFAQ37154646-7B213495-E265-4F59-BC42-8662C7D97A02Q37250411-897BB368-959F-4C16-B463-8C269C1EAC9CQ37261835-3E83A41E-6603-45A1-A651-801018ED7ADCQ38206276-39DE9D6D-F3F1-4E4F-92E1-EB718EE245EDQ38211029-F04EBC0F-558C-4745-8C5C-B5710BAB30BDQ38225901-A43A4BD1-F2AA-4B34-AE13-EE619BDC298CQ38262848-5C90F91A-7313-4156-98A1-BC864ED33B79Q38284474-9D426316-154A-44DC-B5E7-B9AC5F76548BQ38652295-E284E9E6-9B30-413C-8B3F-EF528B8E4636Q38739253-C4C8CF89-7CBA-49B3-9369-1F8A4B2B1D0CQ38782122-7CC7CEF9-EF01-4B32-A3F6-7C4617E4020DQ38791824-0A121131-962E-47BD-B12A-02D04C8C0D2BQ39050679-1C13EB98-E829-48E7-A8E4-FF46E9136F36Q39078623-70B9E988-94B2-4878-9698-F0DAECF5C31EQ39208882-3010F43C-823E-4C3C-9F9C-C7DFD8EA3FA2Q39259845-E4CF0E1A-D832-4A4C-83E6-903DB997FD07Q39438064-69ADF713-F7DC-4480-B7A8-F3D88B3CF083Q40289620-6E7DFBBC-1E6C-4673-A759-B7C8CB4E9C8EQ40889732-8C02CE83-37DC-4ADA-A82A-8D6368D513F0Q40897111-5AD7E575-A75B-40F6-BA22-AD670CD18E89Q41386758-BDD6CFBF-FFD4-42F1-BAF9-ABBB7AAE6919Q41519389-7831C792-88F0-4776-ACB1-1C29646F8817Q41628017-DF4ECA91-A69E-4B11-98A4-7120F9BE7CFDQ42199825-9609A506-6C3C-433E-8345-EFA1B1E322A2Q42739353-C31E6732-9EE7-4C66-A34F-F2C92DB514D9Q46018019-7BB10490-DEA9-441A-827C-07CD3C3EECD4Q47113903-B2042501-8F9C-4EAA-9FEA-E1054042ACFBQ47128186-A48C1FE2-1230-434E-BA90-B33F06D2B1C6
P2860
Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@ast
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@en
type
label
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@ast
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@en
prefLabel
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@ast
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@en
P2093
P2860
P921
P356
P1433
P1476
Survival and secondary tumors ...... 's Oncology Group trial A9961.
@en
P2093
Amar Gajjar
Emi Holmes
Gilbert Vezina
Roger J Packer
Tianni Zhou
P2860
P304
P356
10.1093/NEUONC/NOS267
P577
2012-10-25T00:00:00Z